Cannabidiol for alcohol withdrawal symptoms and cravings
About this title
Read the official source — NCT07148843Understand this study
Who could participate?
Listed age limits: 21 years to 65 years.
What will I do during this study?
Participants stay in the hospital research unit for five days and four nights during alcohol withdrawal care. They are randomly assigned to low-dose CBD, higher-dose CBD or placebo (an inactive comparison treatment) in addition to standard care, and complete withdrawal and sleep assessments and provide breath and blood samples.
- Listed locations
- BaltimoreSee all locations and recruitment
- Study phase
- Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
What to know before participating
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 105
- Sponsor
- Johns Hopkins University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- United States
- Age range
- From 21 Years to 65 Years
- Official registry ID
- NCT07148843
- Official title
Show the full official title
Cannabidiol as an Adjunct Treatment for Alcohol Withdrawal and Craving
Recruitment & locations
Baltimore
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Johns Hopkins University, a university.
Does this study involve medication?
Yes. The study involves medication, including Cannabidiol (CBD) and Placebo.
Who can participate?
Listed age limits: 21 years to 65 years.
Is this study still recruiting?
The registry lists this study as recruiting.
